BioCharger – The Original Bioelectric Light Stimulator (BELS) Device

After Tesla died, his work was continued by his protégé, Dr. Orville Fitz, who conducted research with Tesla in the mid to late 1930s, investigating the separation of non-ferrous metals from mineral sources using applied pulsed electromagnetic fields.

After studying the Tesla literature, James Girard, the inventor of the BioCharger units, located Dr. Fitz through a friend and contacted him. After some discussion, Dr. Fitz agreed to let Girard live and study with him. Girard lived and worked with Dr. Fitz in Texas for a period of 6 months from the fall of 1988 to the spring of 1989. During this time, Girard absorbed as much as he could from Tesla’s colleague.

After studying first hand with Tesla’s protégé, witnessing remarkable inventions, and reviewing the research literature on electrotherapy and the MWO, James Girard designed the BioCharger unit as a Tesla Coil wired in series with noble gasified low vacuum tubes. He added the unique Rodin Toroid Coil half-capacitor terminal to the top of the device. This variation of Tesla’s disruption coil design enables the BioCharger unit to function as a more powerful transmitter. This design consideration is important in our attempt to non-invasively (wirelessly) transmit electromagnetic energy to mitochondria to induce currents in to drive ATP generation.

BioCharger Advanced 

Introduced in 2005, the BioCharger ADVANCED 1988 Model was re-designed, offering a superior NEMA-4X rated enclosure for added safety. Designed for rigorous, intermittent personal use with both the home user and professional technician in mind, the BioCharger ADVANCED 1988 Model also offered improved operational features. It included an automatic timer and a partially shielded transmitter output that selectively targeted users, only to minimize technician over-exposure and/or stray transmission concerns.

The BioCharger ADVANCED 1988 Model combined the work of early energy pioneers Tesla, Lahkovsky, AND Royal Rife by incorporating an exclusive new option: a variable power input control that provided modulation of the output signal and Rife modality energy benefits to the device.

The exclusive BioCharger ADVANCED 1988 Model design features offer multiple energy modalities, including Pulsed Electromagnetic Frequency (PEMF) and Photon delivery, Monochromatic Light, and Micro-Current Therapy, as well as other unique benefits. PEMF and Photon components communicate with the body on a cellular and subcellular level to recharge and rejuvenate dysfunctional cells and body systems back to their optimal state. The high-frequency EM radio-wave type transmissions deliver micro-current energy deep within the body’s tissues, removing energetic blockages and restoring balance. The benefits of full-spectrum Monochromatic Light Therapy are well documented to affect every single part of the brain and every cell of the body.

BioCharger 2012 Model – Previous Generation

In 2002-2003, Girard built the classic BioCharger “88” model which still used the spark-gap Tesla coil but introduced a basic variable pulsing feature that was later refined in the BioCharger “2012” model. The pulse feature offered three selected pulse mode capabilities: at 4, 8, and 20 hertz [cycles per second].

The limitations of the older spark-gap design prevented precise pulsing at frequencies higher than 60 hertz.

NOTE: ALL the MWOs currently on the market used an OLD antiquated spark gap design from the early 1900s (this includes the Old BioCharger units up to BioCharger 2012, Tesla Energy Lights, Quantum Pulse, and All Lakhovsky MWO machines).

Consequently, the goal of the next model was to incorporate a more advanced vacuum tube design to allow for selected higher frequencies at which to pulse the coil. However, the limitation of this design is that the vacuum tubes would not pulse at the higher Rife (Raymond Royal Rife frequencies and were limited to approx 1,000 hertz, far less than the 50,000 hertz [50 kilo-hertz] Rife utilized). Another drawback was that this model was very cumbersome, weighing about 100 lbs.

Only the BioCharger NG took a quantum leap to solid state bypassing even vacuum tube technologies, which would be an upgrade from spark gap, but still outdated compared to digital solid state (think vacuum tube computers vs solid state (with integrated circuits)).

NEW GENERATION – BioCharger NG

As radio technology precision improved with solid-state circuitry, so did Girard’s vision of what could be accomplished through using a solid-state Tesla-coil with finely tuned precision over a far wider range of frequencies (i.e. pulse frequency of 1 to 50 kilohertz, output frequencies of 9 kilohertz [9,000 hertz] to 1 Gigahertz [1 X 109 = 1,000,000,000 hertz] and into the visible light spectrum [1 X 1012-16 Hertz]). Girard began working on the BioCharger “Plus” with a vision to provide a hybrid of Rife, Gurwitsch & Lakhovsky technologies in a single, unique, combined platform, never before offered in the marketplace.

From Evolution to Revolution

Just as Girard’s company, Advanced Technology Concepts (ATC), was about to release the BioCharger “Plus”, Girard was approached by a small team of veteran entrepreneurs who had been following his progress. Although they were impressed with the concept and the positive results they had heard from customers and users, they saw a larger opportunity to transform the BioCharger into something far greater. It was clear that by combining their experience, expertise, and resources with Girard’s initial concepts, a next-generation health optimization platform could be developed…the BioCharger NG.

Advanced Biotechnologies, LLC was formed in 2013 and acquired all rights and intellectual property related to the BioCharger. They brought Girard in as a partner, and since then the team has been focused on the design, development, production, and testing of the BioCharger NG. In addition, they’ve been awarded US and International trademarks, and have a patent pending with 13 specific claims; further evidence that what they are doing is nothing short of a breakthrough. Just as the company has secured strong relationships with its engineering and manufacturing partners, they have made the investment in retaining the best breed of patent and regulatory representation, to ensure its long-term success.